Literature DB >> 8422771

Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland.

O I Siitonen1, L K Niskanen, M Laakso, J T Siitonen, K Pyörälä.   

Abstract

OBJECTIVE: To study the incidence of LEAs attributable to PVD in diabetic and nondiabetic patients. The age at first amputation, the level of amputation, the number of reamputations, and survival after amputation also were examined in the study populations. RESEARCH DESIGN AND METHODS: This retrospective study was based on a population of 253,000 inhabitants in eastern Finland. All patients with their first LEA performed during the period from 1 January 1978 to 31 December 1984 were identified from the registers of operation theaters in the study area. Furthermore, patient records and death certificates were reviewed. Amputations attributable to causes other than evident atherosclerotic vascular disease were excluded.
RESULTS: Altogether, 477 patients (85 diabetic men, 127 nondiabetic men, 169 diabetic women, and 96 nondiabetic women) were identified. The overall LEA rate was 26.9/100,000 per yr, and the incidence increased strongly with age in both diabetic and nondiabetic patients. The age-adjusted amputation incidence per yr was 349.1/100,000 for diabetic men, 33.9/100,000 for nondiabetic men, 239.4/100,000 for diabetic women, and 17.2/100,000 for nondiabetic women. The proportion of peripheral (toe, leg) amputations was markedly higher in diabetic patients who also tended to have more reamputations during the follow-up than did nondiabetic subjects. The diabetic status per se was a statistically significant risk factor for mortality in women, but not in men.
CONCLUSIONS: Diabetic men and women had a 10.3- and 13.8-fold higher risk, respectively, for LEA.

Entities:  

Mesh:

Year:  1993        PMID: 8422771     DOI: 10.2337/diacare.16.1.16

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  29 in total

1.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

Review 2.  Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds.

Authors:  Giovanni Marfia; Stefania Elena Navone; Clara Di Vito; Nicola Ughi; Silvia Tabano; Monica Miozzo; Carlo Tremolada; Gianni Bolla; Chiara Crotti; Francesca Ingegnoli; Paolo Rampini; Laura Riboni; Roberta Gualtierotti; Rolando Campanella
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

Review 3.  Screening for the high-risk foot of ulceration: tests of somatic and autonomic nerve function.

Authors:  Vasiliki Argiana; Ioanna Eleftheriadou; Nicholas Tentolouris
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

Review 4.  Debridement of diabetic foot ulcers.

Authors:  Jude Edwards; Sally Stapley
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

5.  Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?

Authors:  Christopher G Elliott; Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2011-04-19       Impact factor: 5.782

6.  Retinopathy as a predictor of other diabetic complications.

Authors:  A M El-Asrar; K A Al-Rubeaan; S A Al-Amro; O A Moharram; D Kangave
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

Review 7.  Gender differences in diabetes-related lower extremity amputations.

Authors:  Monica E Peek
Journal:  Clin Orthop Relat Res       Date:  2011-07       Impact factor: 4.176

8.  Change in amputation predictors in diabetic foot disease: effect of multidisciplinary approach.

Authors:  Kadriye Aydin; Mehlika Isildak; Jale Karakaya; Alper Gürlek
Journal:  Endocrine       Date:  2010-06-20       Impact factor: 3.633

9.  Clinico-microbiological study and antibiotic resistance profile of mecA and ESBL gene prevalence in patients with diabetic foot infections.

Authors:  Waqas Nasir Chaudhry; Rabia Badar; Muhsin Jamal; Jason Jeong; Jamal Zafar; Saadia Andleeb
Journal:  Exp Ther Med       Date:  2016-01-14       Impact factor: 2.447

Review 10.  [Diabetic complications. Micro and macroangiopathic end-organ damage].

Authors:  U D Lichtenauer; J Seissler; W A Scherbaum
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.